Brind.

The Gates Foundation provided grant funding for AI-Immunology platform research, and the EIB helped Evaxion by converting debt to equity.

3 reports, 2 independent Updated Jun 11
Gone quiet
Reports
3
Developments
3
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

The Gates Foundation provided grant funding for AI-Immunology platform research, and the EIB helped Evaxion by converting debt to equity.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. MMV and deepmirror continue their partnership, utilizing an AI tool to target diseases like malaria, supported by a $5 million grant from the Gates Foundation.Sub-event
  2. Evaxion presented research data at the EHA Congress in Stockholm.1 source
  3. Grant funding from the Gates Foundation supports Evaxion's AI-Immunology research, alongside an EIB agreement.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • finanznachrichten.de
  • GlobeNewswireEvaxion announces business update and second quarter 2025 financial results COPENHAGEN, Denmark, August 14, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializin
  • GlobeNewswireEvaxion finalizes agreement with EIB to convert debt into equity Evaxion and the European Investment Bank (EIB) have finalized a debt settlement agreement of €3.5 million out of Evaxion’s €7 million